Overview
Clinical Benefits
- Skin repair
- Anti-inflammatory effects
- Gene expression modulation
- Wound healing support
Administration
Subcutaneous injection OR topical serum (2% concentration)
Drug class: tripeptide
Clinical Dosing
Typical dosage
1-3mg daily (injectable) or 2% topical
Starting dose
1mg
Cadence
Once daily
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-4 | 1mg once daily (injectable) or 2% topical serum |
| Weeks 5-12 | 2-3mg daily or continue topical |
Safety Profile
Side effects
- • Well tolerated
- • Mild injection site reactions
Contraindications
- • Active cancer
- • Pregnancy
Frequently asked questions
GHK (Glycyl-Histidyl-Lysine) is most commonly researched for: Skin repair, Anti-inflammatory effects, Gene expression modulation, Wound healing support.
Ready to build a protocol with GHK (Glycyl-Histidyl-Lysine)?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.